Our friends at R and D Systems/Tocris Bioscience have made available to us select Small Molecules/Peptides. Our focus will be on providing agonists, antagonists, inhibitors and ligands that complement our Neuroscience and Pain Research products and expertise.
We will be adding about 10 new molecules/peptides per month. Here's a sampling our our most recent additions:
| Name | Type | Bioactivity |
|---|---|---|
| (±)-trans-ACPD | Agonist | Potent NMDA agonist. Also group II mGluR agonist |
| (S)-(-)-5-Fluorowillardiine | Agonist | Very potent AMPA agonist |
| (S)-4-Carboxyphenylglycine | Antagonist | Competitive group I mGluR antagonist/weak group II agonist |
| 2-APB | Modulator | TRP channel modulator. Also IP3 receptor antagonist |
| 2-Methylthioadenosine triphosphate tetrasodium salt | Agonist | P2 purinergic agonist |
| AM 404 | Modulator | Vanilloid receptor agonist. Also anandamide transport inhibitor |
| BRL 52537 hydrochloride | Ligand | Potent and selective κ opioid receptor agonist |
| CNQX | Antagonist | Potent AMPA/kainate antagonist |
| Clocinnamox mesylate | Antagonist | Irreversible μ-opioid receptor antagonist |
| Endomorphin-1 | Agonist | Potent and selective μ opioid receptor agonist |
| Endomorphin-2 | Agonist | Potent and selective μ opioid receptor agonist |
| FIT | Agonist | Irreversible δ opioid receptor agonist |
| GBR 13069 dihydrochloride | Agonist | Potent dopamine uptake inhibitor |
| L-NIO dihydrochloride | Inhibitor | Potent eNOS inhibitor |
| L-Quisqualic acid | Agonist | Very potent group I mGluR agonist |
| N-Benzylnaltrindole hydrochloride | Agonist | Opioid receptor selective non-peptide antagonist |
| Nociceptin | Inhibitor | Endogenous NOP agonist |
| O-Phospho-L-serine | Antagonist | Group III mGluR agonist; enhances neuronal differentiation |
| Ro 51 | Antagonist | Potent P2X3, P2X2/3 antagonist |
| cis-ACPD | Agonist | Potent NMDA agonist. Also group II mGluR agonist |

No comments:
Post a Comment